Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
Publication|Videos|October 3, 2024

Parexel’s FSP: Evolving With Your Needs Now and in the Future

Author(s)PAREXEL

Jenny Denney, EVP, Head of FSP Clinical and Biometrics at Parexel, discusses current transformations in the industry in addition to how Parexel, as the landscape shifts, supports clients with proper models and infrastructure from a functional service provider (FSP) perspective.

• A one-size-fits-all model no longer exists. Because of this, Parexel's models are flexible and agile, designed to adapt to customer needs and their shifting pipeline priorities—and whatever challenges they face.
• One of Parexel's key differentiators is its people-centric approach. The company does everything with heart. While technology plays a significant role in transforming the industry, it is ultimately powered by Parexel's dedicated people.
• Parexel has a remarkable global infrastructure that spans across numerous countries. This infrastructure allows it to provide real-time connectivity and ensures it can find the right people in the right place at the right time, which is essential for the success of the FSP model.


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.